A review of more than 100 spontaneous reports of confirmable cases of AKI related to SGLT2i led the US Federal Drug Administration (FDA) to issue a warning in December 2015 stating that SGLT2 inhibitors might cause AKI [11]. Here, SLC5A2 is linked to acute kidney injury.